- Home
- GPRE vs MRVI Comparison
GPRE vs MRVI Comparison
Compare GPRE & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRE
- MRVI
- Stock Information
- Founded
- GPRE 2004
- MRVI 2014
- Country
- GPRE United States
- MRVI United States
- Employees
- GPRE N/A
- MRVI N/A
- Industry
- GPRE Major Chemicals
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- GPRE Industrials
- MRVI Health Care
- Exchange
- GPRE Nasdaq
- MRVI Nasdaq
- Market Cap
- GPRE 289.7M
- MRVI 312.4M
- IPO Year
- GPRE N/A
- MRVI 2020
- Fundamental
- Price
- GPRE $7.21
- MRVI $2.74
- Analyst Decision
- GPRE Buy
- MRVI Hold
- Analyst Count
- GPRE 7
- MRVI 10
- Target Price
- GPRE $10.42
- MRVI $6.84
- AVG Volume (30 Days)
- GPRE 2.0M
- MRVI 1.9M
- Earning Date
- GPRE 08-05-2025
- MRVI 08-06-2025
- Dividend Yield
- GPRE N/A
- MRVI N/A
- EPS Growth
- GPRE N/A
- MRVI N/A
- EPS
- GPRE N/A
- MRVI N/A
- Revenue
- GPRE $2,463,097,000.00
- MRVI $241,856,000.00
- Revenue This Year
- GPRE $2.90
- MRVI N/A
- Revenue Next Year
- GPRE $1.54
- MRVI $10.62
- P/E Ratio
- GPRE N/A
- MRVI N/A
- Revenue Growth
- GPRE N/A
- MRVI N/A
- 52 Week Low
- GPRE $3.14
- MRVI $1.67
- 52 Week High
- GPRE $18.14
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- GPRE 84.31
- MRVI 67.32
- Support Level
- GPRE $5.60
- MRVI $2.56
- Resistance Level
- GPRE $5.88
- MRVI $2.72
- Average True Range (ATR)
- GPRE 0.37
- MRVI 0.16
- MACD
- GPRE 0.13
- MRVI 0.05
- Stochastic Oscillator
- GPRE 97.16
- MRVI 89.30
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.